A61K 40/4259
Sialyl-thomson-nouvelle antigen [stn]
Official title: {Sialyl-Thomson-nouvelle antigen [sTn]}
A61K40/4259 (Sialyl-thomson-nouvelle antigen [stn]) appears on 2 US grants and 6 published applications in this corpus.
Search patents in A61K- Granted patents
- 2
- Published applications
- 6
- Assignees
- 7
- Inventors
- 21
- Latest grant
- 26 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 3 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Improved glycan-dependent immunotherapeutic bi-specific proteins with longer half-life27 Nov 2025US 2025/0361318 A1The Regents of the University of California
- Application of multimer in detection and preparation of car-expressing cell31 Oct 2024US 2024/0361328 A1
- Chimeric antigen receptors to sialyl-tn glycan antigen4 Jul 2024US 2024/0216510 A1
- Humanized anti-sialyl-tn glycan antibodies and uses thereof20 Jun 2024US 2024/0197882 A1Ramot at Tel-Aviv University Ltd.
- Cancer treatment with 237 car-t cell based therapeutics recognizing the tn epitope17 Feb 2022US 2022/0047631 A1The Board of Trustees of the University of Illinois
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.